2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Cough: new trials by email Literature Review of Cough trials Research Report on Cough
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes Camlipixant - Cough | Phase 1 | Withdrawn | GlaxoSmithKline | 2026-07-02 | 2026-08-31 | |
| Pulmozyme for Sjogren's Associated Cough Dornase alfa, Saline - Sjogren's Syndrome, Cough | Phase 1 | Withdrawn | UConn Health | 2011-05-01 | 2020-01-18 |
Chronic Cough (1) · Sjogren's Syndrome (1)
Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Lacrimal Apparatus Diseases (1) · Mouth Diseases (1)
Sodium Chloride (1) · dornase alfa (1)
GlaxoSmithKline (1) · UConn Health (1)
United Kingdom (1) · United States (1)